IL41664A - 2,6-Diamino-dihydropyridines and their pharmaceutical preparations - Google Patents

2,6-Diamino-dihydropyridines and their pharmaceutical preparations

Info

Publication number
IL41664A
IL41664A IL7341664A IL4166473A IL41664A IL 41664 A IL41664 A IL 41664A IL 7341664 A IL7341664 A IL 7341664A IL 4166473 A IL4166473 A IL 4166473A IL 41664 A IL41664 A IL 41664A
Authority
IL
Israel
Prior art keywords
compound
radical
alkyl
radicals
alkoxy
Prior art date
Application number
IL7341664A
Other languages
English (en)
Hebrew (he)
Other versions
IL41664A0 (en
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL41664A0 publication Critical patent/IL41664A0/xx
Publication of IL41664A publication Critical patent/IL41664A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
IL7341664A 1972-03-06 1973-03-02 2,6-Diamino-dihydropyridines and their pharmaceutical preparations IL41664A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2210687A DE2210687C3 (de) 1972-03-06 1972-03-06 2,6-Diamino-3,5-diäthoxycarbonyldihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
IL41664A0 IL41664A0 (en) 1973-05-31
IL41664A true IL41664A (en) 1976-01-30

Family

ID=5838037

Family Applications (1)

Application Number Title Priority Date Filing Date
IL7341664A IL41664A (en) 1972-03-06 1973-03-02 2,6-Diamino-dihydropyridines and their pharmaceutical preparations

Country Status (24)

Country Link
JP (2) JPS5626659B2 (de)
KR (1) KR780000119B1 (de)
AT (3) AT327904B (de)
BE (1) BE796279A (de)
BG (2) BG22815A3 (de)
CA (1) CA988524A (de)
CH (2) CH577473A5 (de)
CS (2) CS182781B2 (de)
DD (1) DD106833A5 (de)
DE (1) DE2210687C3 (de)
DK (1) DK136061C (de)
ES (1) ES412323A1 (de)
FI (1) FI55996C (de)
FR (1) FR2181789B1 (de)
GB (1) GB1379005A (de)
HU (1) HU167089B (de)
IE (1) IE37370B1 (de)
IL (1) IL41664A (de)
LU (1) LU67147A1 (de)
NL (1) NL7303137A (de)
PL (2) PL89256B1 (de)
RO (2) RO63068A (de)
SE (1) SE384208B (de)
ZA (1) ZA731501B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2210687C3 (de) * 1972-03-06 1981-09-24 Bayer Ag, 5090 Leverkusen 2,6-Diamino-3,5-diäthoxycarbonyldihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE2406198C2 (de) * 1974-02-09 1983-12-15 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von neuen 2-Amino-6-dialkylamino-dihydropyridinen
JPS5922593U (ja) * 1982-08-03 1984-02-10 日本マランツ株式会社 ヘツドホ−ン用ホ−ン部取付構造
JPS5922594U (ja) * 1982-08-03 1984-02-10 日本マランツ株式会社 耳栓型ヘツドホ−ン
JPS6282898A (ja) * 1985-10-08 1987-04-16 Matsushita Electric Ind Co Ltd ヘツドホン
JPS6293060U (de) * 1985-11-28 1987-06-13

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3855231A (en) * 1972-03-06 1974-12-17 Bayer Ag 2,6-diamino-1,4-dihydropyridine derivatives
DE2210687C3 (de) * 1972-03-06 1981-09-24 Bayer Ag, 5090 Leverkusen 2,6-Diamino-3,5-diäthoxycarbonyldihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE2406198C2 (de) * 1974-02-09 1983-12-15 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von neuen 2-Amino-6-dialkylamino-dihydropyridinen

Also Published As

Publication number Publication date
PL89256B1 (de) 1976-11-30
CH577473A5 (de) 1976-07-15
HU167089B (de) 1975-08-28
KR780000119B1 (en) 1978-04-15
IE37370B1 (en) 1977-07-06
DK136061B (da) 1977-08-08
JPS5699460A (en) 1981-08-10
ATA925774A (de) 1975-05-15
IL41664A0 (en) 1973-05-31
GB1379005A (en) 1975-01-02
DE2210687C3 (de) 1981-09-24
CA988524A (en) 1976-05-04
DE2210687A1 (de) 1973-09-20
RO63068A (de) 1978-05-15
LU67147A1 (de) 1973-05-22
ZA731501B (en) 1973-11-28
CH580589A5 (de) 1976-10-15
JPS5626659B2 (de) 1981-06-19
PL92078B1 (de) 1977-03-31
ES412323A1 (es) 1976-01-01
NL7303137A (de) 1973-09-10
JPS48103579A (de) 1973-12-25
DD106833A5 (de) 1974-07-05
DK136061C (da) 1978-01-02
SE384208B (sv) 1976-04-26
BG22815A3 (bg) 1977-04-20
BE796279A (fr) 1973-09-05
AT324338B (de) 1975-08-25
DE2210687B2 (de) 1980-09-04
FR2181789B1 (de) 1976-12-03
IE37370L (en) 1973-09-06
CS182781B2 (en) 1978-05-31
FI55996B (fi) 1979-07-31
FR2181789A1 (de) 1973-12-07
FI55996C (fi) 1979-11-12
RO61192A (de) 1976-09-15
JPS5911584B2 (ja) 1984-03-16
AT327904B (de) 1976-02-25
BG20583A3 (bg) 1975-12-05
CS182792B2 (en) 1978-05-31

Similar Documents

Publication Publication Date Title
US3897444A (en) Pharmacologically active compounds
DE69223157T2 (de) Sauerstoff-substituierte derivate von nucleophil-stickstoffoxid-addukten und ihre verwendung als stickstoffoxid-donor-prodrugs
SI9300452A (en) Substituted thiazolidinedione derivates
DE69011569D1 (de) Verbindungen der 1-Azabicyclo(3.2.0)hept-2-en-2-carbonsäure.
IL41669A (en) Condensed pyridine compounds their production and pharmaceutical compositions containing them
IE57675B1 (en) 5-pyrimidinecarboxamides and thiocarboxamides and treatment of leukemia and tumors therewith
IL41664A (en) 2,6-Diamino-dihydropyridines and their pharmaceutical preparations
US3920822A (en) Inhibition of histamine activity with cyanoguanidines
KR900014396A (ko) 티에노-트리아졸로-디아제핀 유도체, 그의 제조 방법 및 그를 함유하는 치료 조성물
EA002037B1 (ru) Цианогуанидины в качестве ингибиторов пролиферации клеток
IL43079A (en) 2-amino-1,4-dihydropyridines,their production and pharmaceutical compositions containing them
GB2073752A (en) 2,6-diaminobularines
US3470297A (en) Coronary dilating compositions and their administration
GB1045180A (en) Quinazoline derivatives
KR950001040B1 (ko) 티오우레아 유도체 및 이를 함유하는 항균제 및 항궤양제
EP0041792B1 (de) Platinverbindungen mit Antitumor- oder Antimikrobial-Aktivität und diese enthaltende pharmazeutische Zubereitungen
JPH0257523B2 (de)
IL43063A (en) 2-phenoxy-1-imidazolyl-alkan-3-ones their production and pharmaceutical compositions containing them
JPH1087492A (ja) 一酸化窒素産生阻害剤
DE60025826T2 (de) Pyrazolidinol-verbindungen
IL42745A (en) 2-amino-4-h-pyrane derivatives,their production and pharmaceutical compositions containing them
KR900014322A (ko) 치환(퀴놀린-2-일-메톡시)페닐-n.n-술포닐우레아, 그의 제조방법 및 약물 용도
US4329355A (en) Mesoionic antitumor compositions and methods for using the same in the treatment of cancer
JPS62919B2 (de)
US3634506A (en) Process for the manufacture of biguanide derivatives